Gene · 51455
Papers1,571
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,571
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A non-proteolytic release mechanism for HMCES-DNA-protein crosslinks. | EMBO J | 2023 | 37519246 | PubTator, text mining | PubMed |
| BRCT Domains: Structure, Functions, and Implications in Disease-New Therapeutic Targets for Innovative Drug Discovery against Infections. | Pharmaceutics | 2023 | 37514027 | PubTator, text mining | PubMed |
| CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2023 | 37509260 | PubTator, text mining | PubMed |
| Reprogramming human B cells with custom heavy chain antibodies. | Res Sq | 2023 | 37503066 | PubTator, text mining | PubMed |
| Spontaneous mutagenesis in human cells is controlled by REV1-Polymerase ζ and PRIMPOL. | Cell Rep | 2023 | 37498746 | PubTator, text mining | PubMed |
| Rev1 deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD+ precursor nicotinamide riboside. | Heliyon | 2023 | 37484291 | PubTator, text mining | PubMed |
| The peroxidation-derived DNA adduct, 6-oxo-M1dG, is a strong block to replication by human DNA polymerase η. | J Biol Chem | 2023 | 37468099 | PubTator, text mining | PubMed |
| DPPA5A suppresses the mutagenic TLS and MMEJ pathways by modulating the cryptic splicing of Rev1 and Polq in mouse embryonic stem cells. | Proc Natl Acad Sci U S A | 2023 | 37459543 | PubTator, text mining | PubMed |
| Bypass of Abasic Site-Peptide Cross-Links by Human Repair and Translesion DNA Polymerases. | Int J Mol Sci | 2023 | 37446048 | PubTator, text mining | PubMed |
| The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork. | Int J Mol Sci | 2023 | 37445667 | PubTator, text mining | PubMed |
| Editorial: Enhanced biological mechanism study, drug discovery and individualized medicine with single-cell multiomics data and integrative analysis. | Front Genet | 2023 | 37434951 | PubTator, text mining | PubMed |
| Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis. | RSC Chem Biol | 2023 | 37415867 | PubTator, text mining | PubMed |
| The diagnostic significance of the ZNF gene family in pancreatic cancer: a bioinformatics and experimental study. | Front Genet | 2023 | 37396042 | PubTator, text mining | PubMed |
| A formamidopyrimidine derivative from the deoxyguanosine adduct produced by food contaminant acrylamide induces DNA replication block and mutagenesis. | J Biol Chem | 2023 | 37394003 | PubTator, text mining | PubMed |
| Phase Separation Modulates the Formation and Stabilities of DNA Guanine Quadruplex. | JACS Au | 2023 | 37388701 | PubTator, text mining | PubMed |
| Establishing a prognostic model based on five starvation-related long non-coding RNAs for clear cell renal cell carcinoma. | Aging (Albany NY) | 2023 | 37341994 | PubTator, text mining | PubMed |
| Similar deamination activities but different phenotypic outcomes induced by APOBEC3 enzymes in breast epithelial cells. | Front Genome Ed | 2023 | 37324648 | PubTator, text mining | PubMed |
| Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. | Front Pharmacol | 2023 | 37324459 | PubTator, text mining | PubMed |
| Genetic and epigenetic background of diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | 37324271 | PubTator, text mining | PubMed |
| Experimental systems for the analysis of mutational signatures: no 'one-size-fits-all' solution. | Biochem Soc Trans | 2023 | 37283472 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51455/papers?page=6